JW (Cayman) Therapeutics Co Ltd JNY:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 03/21/24 CET
0.248UNCH (UNCH)
52 week range
0.18 - 0.33
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.248
  • 52 Week High0.33
  • 52 Week High Date11/09/23
  • 52 Week Low0.18
  • 52 Week Low Date02/02/24

Key Stats

  • Market Cap99.8M
  • Shares Out412.98M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.248
  • 52 Week High0.33
  • 52 Week High Date11/09/23
  • 52 Week Low0.18
  • 52 Week Low Date02/02/24
  • Market Cap99.8M
  • Shares Out412.98M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.24
  • P/E (TTM)-1.03
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On JW (Cayman) Therapeutics Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
JW Cayman Therapeutics Co Ltd is a China-based company mainly engaged in the clinical and pre-clinical stage cell therapy. The Company is focuses on developing cell therapies for the China market to transform the treatment of cancer for Chinese patients. Through its subsidiary, it has built an integrated platform focused on developing, manufacturing and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its main product...
Li Yiping M.D.
Executive Chairman, Chief Executive Officer
Address
No 225 Meisheng Road
Pilot Free Trade Zone, 4f, Building 42
Shanghai, SHA
KY1-1104
China